Dashboard M. tuberculosis
Repurposing candidates for M. tuberculosis
Mycobacterium tuberculosis
Approved medicines with AI-predicted activity ≥40% against M. tuberculosis, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 1,072
- Existing antimicrobials set aside
- 128
- Needing review
- 74
- Repurposing candidates
- 870
Repurposing candidates for M. tuberculosis
AI prediction · nothing measuredAll 870 repurposing candidates for M. tuberculosis.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- ChlordiazepoxideExisting use: Alcohol dependence, Anxiety, Anxiety disorder63.0% AI-predicted activityagainst M. tuberculosis8 registered studies
- PrazepamExisting use: Anxiety63.0% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- TriazolamExisting use: Insomnia63.0% AI-predicted activityagainst M. tuberculosis17 registered studies
- Cetrorelix AcetateExisting use: Ovulation Inhibition, Positive regulation of ovulation62.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Naldemedine TosylateExisting use: Constipation, Constipation disorder62.7% AI-predicted activityagainst M. tuberculosis1 registered study
- PolythiazideExisting use: Cardiovascular disease62.7% AI-predicted activityagainst M. tuberculosis1 registered study
- CabotegravirExisting use: HIV infection, HIV-1 infection, Viral disease62.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Ponatinib HydrochlorideExisting use: Acute lymphoblastic leukemia, Chronic myelogenous leukemia, Lymphoid leukemia and 1 more62.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- SiponimodExisting use: Multiple sclerosis62.6% AI-predicted activityagainst M. tuberculosis33 registered studies
- SitagliptinExisting use: Diabetes mellitus, Hyperlipidemia, Myocardial infarction and 2 more62.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Fosamprenavir CalciumExisting use: HIV infection, Immunodeficiency disease, Viral disease62.5% AI-predicted activityagainst M. tuberculosis50+ registered studies
- AbarelixExisting use: Neoplasm62.5% AI-predicted activityagainst M. tuberculosis5 registered studies
- TicagrelorExisting use: Acute coronary syndrome, Acute myocardial infarction, Coronary artery disease and 6 more62.4% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Quinapril HydrochlorideExisting use: Cardiovascular disease, Diabetes mellitus, Heart failure and 3 more62.3% AI-predicted activityagainst M. tuberculosis33 registered studies
- BelzutifanExisting use: Clear cell renal carcinoma, Hemangioblastoma, Neoplasm and 4 more62.2% AI-predicted activityagainst M. tuberculosis45 registered studies
- ChlorprothixeneExisting use: Psychosis62.2% AI-predicted activityagainst M. tuberculosis4 registered studies
- CrizotinibExisting use: Cancer, Neoplasm, Non-small cell lung carcinoma62.2% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Pacritinib CitrateExisting use: Neoplasm, Polycythemia vera, Primary myelofibrosis62.2% AI-predicted activityagainst M. tuberculosis2 registered studies
- PralatrexateExisting use: Cancer, Mature T-cell and NK-cell non-Hodgkin lymphoma, Neoplasm and 2 more62.1% AI-predicted activityagainst M. tuberculosis44 registered studies
- Methdilazine HydrochlorideExisting use: Allergic disease62.0% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- SirolimusExisting use: Adenoma sebaceum, Angiofibroma, Cancer and 5 more62.0% AI-predicted activityagainst M. tuberculosis50+ registered studies
- AdagrasibExisting use: Neoplasm, Non-small cell lung carcinoma61.9% AI-predicted activityagainst M. tuberculosis40 registered studies
- TrandolaprilExisting use: Cardiovascular disease, Heart failure, Hypertension and 2 more61.9% AI-predicted activityagainst M. tuberculosis29 registered studies
- Almotriptan MalateExisting use: Migraine disorder61.8% AI-predicted activityagainst M. tuberculosis16 registered studies